Trial
NCT00866242
Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Maryland, Baltimore
Collaborators
PATH
Condition
Shigella
Intervention
CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a
Why stopped
Reactogenicity met study halting criteria
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-29